A 1-year follow-on study from a randomised, head-to-head, multicentre, open-label study of two pandemic influenza vaccines in children

A 1-year follow-on study from a randomised, head-to-head, multicentre, open-label study of two pandemic influenza vaccines in children

Introduction: Pandemic influenza A H1N1 infections occurred worldwide from 2009. Children were particularly vulnerable. Novel vaccines were used during the pandemic. Objective: To assess the persistence of antibody to H1N1 influenza 1 year after children aged 6 months to 12 years had been immunised...

Full description

Bibliographic Details
Main Authors: P de Whalley, W Walker, MD Snape, C Oeser, M Casey, P Moulsdale, C Harrill, N Andrews, K Hoschler, B Thompson, C Jones, J Chalk, S Kerridge, R Tomlinson, PT Heath, A Finn, S Faust, E Miller, AJ Pollard
Format: Article
Language:English
Published: NIHR Journals Library 2011-12-01
Series:Health Technology Assessment
Subjects:
influenza a
h1n1
as03b
adjuvanted
vaccine
haemagglutination inhibition
microneutralisation
Online Access:https://doi.org/10.3310/hta15450

Internet

https://doi.org/10.3310/hta15450

Similar Items